Request Demo
Last update 30 May 2026
Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd.
Last update 30 May 2026
Overview
Tags
Respiratory Diseases
Infectious Diseases
Immune System Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20260551
鼾眠颗粒治疗儿童腺样体肥大（肺脾气虚、痰瘀互结证）的随机、双盲、极低剂量平行对照、多中心的Ⅱ期临床试验
[Translation] A randomized, double-blind, very low-dose, parallel-controlled, multicenter phase II clinical trial of snoring-sleep granules for the treatment of adenoid hypertrophy in children (lung and spleen qi deficiency, phlegm and blood stasis syndrome).
CTR20254773
温肺定喘颗粒治疗慢性阻塞性肺疾病稳定期（肺肾气虚兼痰瘀阻肺证）的随机、双盲、安慰剂平行对照、剂量探索、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-exploratory, multicenter phase II clinical trial of Wenfei Dingchuan Granules for the treatment of stable chronic obstructive pulmonary disease (lung and kidney qi deficiency with phlegm and blood stasis obstructing the lungs).
CTR20240031
咳敏胶囊治疗感染后咳嗽（阳虚风寒恋肺证）的随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of Kemin capsules in the treatment of post-infectious cough (Yang deficiency and wind-cold lingering in the lungs syndrome)
100 Clinical Results associated with Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shandong Kangzhonghong Pharmaceutical Technology Development Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 30 May 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
4
Phase 2
Phase 3
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free